Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
V-Tech System is an innovative biotechnology brand and regenerative medicine platform developed by Promoitalia Group and VM Corporation. The company specializes in utilizing synthetic exosomes as intelligent delivery vehicles for bioactive molecules, including high molecular weight polynucleotides (PDRN), biomimetic peptides, and vegetable stem cells. Their proprietary technology targets cellular pathways to stimulate tissue repair, enhance collagen synthesis, and improve extracellular matrix integrity for applications in aesthetics and dermatology. V-Tech System's flagship products, such as the V-Tech Serum and Gel Mask, provide ultra-intensive protocols for skin rejuvenation, bio-lifting, and hair restoration. By mimicking natural intercellular communication, the company is positioning itself as a leader in personalized regenerative therapies and precision cosmeceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on V-Tech System.